RSV F evolution escapes some monoclonal antibodies but does not strongly erode neutralization by human polyclonal sera
{{output}}
Vaccines and monoclonal antibodies targeting the respiratory syncytial virus (RSV) fusion protein (F) have recently begun to be widely used to protect infants and high-risk adults. Some other viral proteins evolve to erode polyclonal antibody neutralization an... ...
